These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30182245)

  • 61. Outcomes research: hope for the future or the latest rage?
    Guadagnoli E; McNeil BJ
    Inquiry; 1994; 31(1):14-24. PubMed ID: 8168906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-country comparisons of health-care costs: the case of cancer treatment in the Nordic countries.
    Kalseth J; Halvorsen T; Kalseth B; Sarheim Anthun K; Peltola M; Kautiainen K; Häkkinen U; Medin E; Lundgren J; Rehnberg C; Másdóttir BB; Heimisdottir M; Bjarnadóttir HH; Køtlum JE; Kilsmark J; Halsteinli V
    Health Policy; 2014 Apr; 115(2-3):172-9. PubMed ID: 24462342
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative effectiveness research in radiation oncology: assessing technology.
    Chen AB
    Semin Radiat Oncol; 2014 Jan; 24(1):25-34. PubMed ID: 24314339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Defining Value in Radiation Oncology: Approaches to Weighing Benefits vs Costs.
    Konski AA
    Oncology (Williston Park); 2017 Apr; 31(4):248-54. PubMed ID: 28412775
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Total hip replacement in the G-DRG-system].
    Kaufmann MM; Franz D; Lassahn C; Siebert CH
    Z Orthop Ihre Grenzgeb; 2007; 145(1):61-7. PubMed ID: 17345545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Introduction of the DRG system from the point of view of private health insurers].
    Fritze J; Miebach J; Hüdig W
    Z Arztl Fortbild Qualitatssich; 2002 Aug; 96(8):505-13. PubMed ID: 12244870
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radiation Oncology Clinical Trial Design: An Opportunity to Evaluate Value.
    Shah C; Ward M; Singer ME
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):674-675. PubMed ID: 31540597
    [No Abstract]   [Full Text] [Related]  

  • 68. Care in the recovery of expendable radioelement source costs.
    Bogardus C
    Adm Radiol; 1994 Nov; 13(11):23-4. PubMed ID: 10139204
    [No Abstract]   [Full Text] [Related]  

  • 69. The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand?
    Smith BD; Haffty BG; Wilson LD; Smith GL; Patel AN; Buchholz TA
    J Clin Oncol; 2010 Dec; 28(35):5160-5. PubMed ID: 20956628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The quality of patient care under the German DRG system using as example the inguinal hernia repair].
    Rudroff C; Schweins M; Heiss MM
    Zentralbl Chir; 2008 Feb; 133(1):51-4. PubMed ID: 18278703
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Development of the 2014 G-DRG system. Departure from coding of secondary diagnoses?].
    Volkmer BG; Kahlmeyer A; Petervari M; Pechoel M
    Urologe A; 2014 Jan; 53(1):27-32. PubMed ID: 24452401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapy on target. Change in HCFA reimbursement helps advance a new radiation technology.
    Becker C
    Mod Healthc; 2001 Jun; 31(24):34, 38. PubMed ID: 11430168
    [No Abstract]   [Full Text] [Related]  

  • 73. [Economic aspects of oncological esophageal surgery : Centralization is essential].
    von Dercks N; Gockel I; Mehdorn M; Lorenz D
    Chirurg; 2017 Jan; 88(1):62-69. PubMed ID: 27882394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The development of a provincial radiation oncology service: the first year report and its implications for future developments.
    Byram D; Joseph D; Bulmer M
    Australas Radiol; 1996 Aug; 40(3):306-9. PubMed ID: 8826740
    [TBL] [Abstract][Full Text] [Related]  

  • 75. What explains DRG upcoding in neonatology? The roles of financial incentives and infant health.
    Jürges H; Köberlein J
    J Health Econ; 2015 Sep; 43():13-26. PubMed ID: 26114589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [What changes for rheumatologists in the G-DRG system 2006?].
    Liedtke-Dyong A; Fiori W; Lakomek HJ; Hülsemann JL; Köneke N; Liman W; Roeder N
    Z Rheumatol; 2006 Jul; 65(4):333-9. PubMed ID: 16791624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of lengths of stay and DRG cost weights in dermatology from 2003 to 2006.
    Wenke A; Müller ML; Babapirali J; Rompel R; Hensen P
    J Dtsch Dermatol Ges; 2009 Aug; 7(8):680-7. PubMed ID: 19250249
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Reimbursement of patients with high costs in a department of otorhinolaryngology of maximum care and refinancing by the German DRG system].
    Bachor E; Neun O; Bogeschdorfer F; Gruen PM
    Laryngorhinootologie; 2005 Aug; 84(8):594-601. PubMed ID: 16080062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Do German DRGs appropriately explain the resource consumption of hospitals? An empirical patient-level cost-data analysis across ten episodes of care].
    Geissler A; Quentin W; Busse R
    Gesundheitswesen; 2014 May; 76(5):284-96. PubMed ID: 24129928
    [TBL] [Abstract][Full Text] [Related]  

  • 80. National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study.
    Shapiro MF; Berk ML; Berry SH; Emmons CA; Athey LA; Hsia DC; Leibowitz AA; Maida CA; Marcus M; Perlman JF; Schur CL; Schuster MA; Senterfitt JW; Bozzette SA
    Health Serv Res; 1999 Dec; 34(5 Pt 1):951-68. PubMed ID: 10591267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.